Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Declomycin

(DEH-kloh-MY-sin)

A substance being studied as a way to detect bone growth in patients receiving bisphosphonates (a type of drug used to treat bone pain caused by some types of cancer) for breast cancer. It binds to newly formed bone. A biopsy is done and bone growth is measured using a special microscope. Declomycin also blocks the uptake of water by the kidney and can bind calcium in bones. It is a type of tetracycline antibiotic and a type of bone-labeling agent. Also called demeclocycline hydrochloride.

Declomycin

Search NCI's Dictionary of Cancer Terms